SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-K/A
(Mark One)
[ X ] Annual Report pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934 For the fiscal year ended December 31, 1997
[ X ] Transition Report pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934 For the transition period from ______ to ______
Commission File Number 0-26806
SHERIDAN HEALTHCARE, INC.
(Exact name of registrant as specified in its charter)
Delaware 04-3252967
State or other jurisdiction of S Employer ID Number)
incorporation or organization)
4651 Sheridan Street, Suite 400, Hollywood, Florida 33021
(Address of principal executive offices, including zip code)
954/987-5822
(Registrant's telephone number, including area code)
Securities registered under Section 12(b) of the Act: None
Securities registered under Section 12(g) of the Act: Common Stock, par value $
.01 (Title of Class)
Indicate by check mark whether the Registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes X No ___
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405
of Regulation S-K is not contained herein, and will not be contained, to the
best of Registrant's knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this Form 10-K or any amendment to this
Form 10-K. [ ]
The aggregate market value of the voting stock held by non-affiliates of the
Registrant was approximately $72.8 million as of March 16, 1998. For purposes of
this determination, shares held by non-affiliates includes all outstanding
shares except for shares of non-voting Class A common stock and shares held by
officers, directors and shareholders beneficially owning 10% or more of the
Registrant's outstanding common stock. The aggregate market value was computed
based on the closing sale price of the Registrant's common stock on March 16,
1998, as reported on the NASDAQ National Market.
As of March 16, 1998, there were 7,901,098 shares of the Registrant's voting
Common Stock, $.01 par value per share outstanding and 296,638 shares of the
Registrant's non-voting Class A Common Stock, $.01 par value per share
outstanding.
<PAGE>
SIGNATURES
----------
Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.
Sheridan Healthcare, Inc.
(Registrant)
Date: April 16, 1998 By: /s/ Michael F. Schundler
-------------------------
Michael F. Schundler
Chief Financial Officer
(principal financial officer)
Pursuant to the requirements of the Securities Exchange Act of 1934, this report
has been signed below by the following persons on behalf of the Registrant and
in the capacities and on the dates indicated.
Signature Title Date
/s/ Mitchell Eisenberg, M.D. Chairman of the Board, April 16, 1998
- ---------------------------- President, Chief Executive
Mitchell Eisenberg, M.D. Officer (Principal Executive
Officer)
/s/ Lewis D. Gold, M.D. Executive Vice President, April 16, 1998
- ---------------------------- Director
Lewis D. Gold, M.D.
/s/ Henry E. Golembesky, M.D. Director April 16, 1998
- -----------------------------
Henry E. Golembesky, M.D.
/s/ Jamie Hopping Director April 16, 1998
- -----------------------------
Jamie Hopping
/s/ Neil A. Natkow, D.O. Director April 16, 1998
- -----------------------------
Neil A. Natkow, D.O.
/s/ Michael F. Schundler Chief Financial Officer April 16, 1998
- ------------------------- (Principal Financial and
Michael F. Schundler Accounting Officer)
<PAGE>
